Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage.
Arakawa N, Ushiki A, Abe M, Matsuyama S, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Miyashita K, Saito K, Nakamura R, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Arakawa N, et al. Among authors: izumi t. Nat Commun. 2022 Oct 4;13(1):5854. doi: 10.1038/s41467-022-33160-9. Nat Commun. 2022. PMID: 36195613 Free PMC article.
Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary Study.
Saito K, Kagawa T, Tsuji K, Kumagai Y, Sato K, Sakisaka S, Sakamoto N, Aiso M, Hirose S, Mori N, Tanaka R, Uraoka T, Takata K, Ogawa K, Mori K, Sato M, Nishiya T, Takamatsu K, Arakawa N, Izumi T, Ohno Y, Saito Y, Takikawa H. Saito K, et al. Among authors: izumi t. Metabolites. 2020 Aug 31;10(9):355. doi: 10.3390/metabo10090355. Metabolites. 2020. PMID: 32878279 Free PMC article.
Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease.
Saito K, Gemma A, Tatsumi K, Hattori N, Ushiki A, Tsushima K, Saito Y, Abe M, Horimasu Y, Kashiwada T, Mori K, Sato M, Nishiya T, Takamatsu K, Sun Y, Arakawa N, Izumi T, Ohno Y, Saito Y, Hanaoka M. Saito K, et al. Among authors: izumi t. Sci Rep. 2022 Nov 17;12(1):19819. doi: 10.1038/s41598-022-24406-z. Sci Rep. 2022. PMID: 36396675 Free PMC article.
Identification of activating enzymes of a novel FBPase inhibitor prodrug, CS-917.
Kubota K, Inaba S, Nakano R, Watanabe M, Sakurai H, Fukushima Y, Ichikawa K, Takahashi T, Izumi T, Shinagawa A. Kubota K, et al. Among authors: izumi t. Pharmacol Res Perspect. 2015 Jun;3(3):e00138. doi: 10.1002/prp2.138. Epub 2015 May 4. Pharmacol Res Perspect. 2015. PMID: 26171222 Free PMC article.
Evaluation of species difference in peripheral lymphocyte reduction effect of CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
Inaba SI, Goto M, Tanaka-Takanaka K, Tanaka H, Tomisato W, Yuita H, Doi-Komuro H, Inoue R, Oshima K, Kagari T, Shimozato T, Izumi T. Inaba SI, et al. Among authors: izumi t. Biopharm Drug Dispos. 2016 Dec;37(9):561-573. doi: 10.1002/bdd.2048. Epub 2016 Nov 14. Biopharm Drug Dispos. 2016. PMID: 27764535
2,245 results